Specialty Pharmacy

Physicians reported inaccurate self-perceptions when it came to opioid prescribing

Top news of the day from across the health care landscape.

Ron Lanton III, Esq, President, True North Political Solutions, discusses how drug manufacturers have responded to the emergence of biosimilars thus far.

Services such as Uber and Lyft that help get patients to their medical appointments could also bring patients to their pharmacies.

Rucaparib demonstrated statistically-significant improvement in progression-free survival for patients in the maintenance treatment setting.

Imraldi, a biosimilar referencing Humira, is expected to launch initially in Europe.

A novel chimera targets the growth factors responsible for certain types of breast cancer.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The final rules clarifies several issues important to pharmacists and hints at further rule-making to address direct and indirect remuneration fees.

According to the study, patients who take a reduced dose of abiraterone with a low-fat meal may cut costs by as much as $300,000.

Top news of the day from across the health care landscape.

Smoking and obesity account for a significant number of cancers worldwide.

Commonwealth Fund researchers present ideas for increasing competition, applying value-based purchasing, and protecting patients from high out-of-pocket costs.

Researchers find that disputed bills amount to $54 billion annually across all health insurers.

Top news of the day from across the health care landscape.

Nivolumab plus ipilimumab demonstrated clinical benefit in previously treated patients with dMMR or MSI-H metastatic colorectal cancer.

Triple-negative and HER2-positive breast cancers may be unlikely to develop lymph node metastases.

The future affordability of health insurance coverage remains a concern for many Americans.

Innovative specialty drugs could result in more payers adopting value-based contracting.

Emergency departments are a safety net for low-income patients, many of whom may be at risk of HIV.

Top news of the day from across the health care landscape.

Researchers collaborate to test acoustic cluster therapy to improve treatment of pancreatic cancer.

Hospital Readmissions Reduction Program established through the Affordable Care Act found to penalize facilities that serve a large number of minority patients.

Mylan hopes to launch its newest HIV drug combo at a discounted cost.

Top news of the day from across the health care landscape.

CAR T-cell therapies and biosimilars require new strategies compared with traditional drugs.